The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

IJMS, Free Full-Text

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

Strategies to overcome cancer multidrug resistance (MDR) through

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

Pharmaceutics, Free Full-Text

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

PDF] Not only P-glycoprotein: Amplification of the ABCB1

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

MDR1 Promotes Intrinsic and Acquired Resistance to PROTACs in

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

Drug resistance: from bacteria to cancer

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

Advancing Targeted Protein Degradation via Multiomics Profiling

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

The drug efflux pump MDR1 promotes intrinsic and acquired

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

Biopharmaceutics and Drug Disposition

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to  PROTACs in cancer cells

The mechanisms of multidrug resistance of breast cancer and